top of page
Investors
Our Journey
May 2015
Company founded in Malaysia
July 2015
Successfully awarded seed grant of USD150,000 by Malaysian government agency, Platcom Ventures
August 2015
Selected by Malaysia Global Innovation & Creativity Centre (MaGIC) for e@Stanford USA Program Batch 2015
November 2018
Launching of biosensor platform for molecular diagnostics
May 2019
Launching of in silico platform for design and validation of oligo-based synthetic antibodies (aptamers)
July 2019
Participated in NextRise 2019 Korea for pitching to regional investors
For more detailed information, please email contact@biogenestech.com
bottom of page